首页TWST • NASDAQ
add
Twist Bioscience Corp
昨日收盘价
$30.06
当日价格范围
$29.07 - $31.75
年度波幅
$24.07 - $55.33
市值
19.03亿 USD
平均交易量
174.60万
市盈率
-
股息率
-
主要交易所
NASDAQ
相关资讯
财务信息
损益表
收入
净收入
| (USD) | 2025年6月info | 年同比变化 |
|---|---|---|
收入 | 9605.70万 | 17.91% |
经营支出 | 8141.70万 | 2.72% |
净收入 | 2039.00万 | 123.83% |
净利润率 | 21.23 | 120.21% |
每股收益 | -0.47 | 33.22% |
息税折旧摊销前利润 | -2405.50万 | 32.60% |
有效税率 | 0.93% | — |
资产负债表
总资产
负债总额
| (USD) | 2025年6月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 2.51亿 | -13.34% |
总资产 | 6.44亿 | 0.86% |
负债总额 | 1.65亿 | 12.54% |
权益总额 | 4.78亿 | — |
发行在外的股份 | 6036.09万 | — |
市净率 | 3.78 | — |
资产回报率 | -12.15% | — |
资本回报率 | -13.61% | — |
现金流
现金净变动
| (USD) | 2025年6月info | 年同比变化 |
|---|---|---|
净收入 | 2039.00万 | 123.83% |
来自运营的现金 | -140.00万 | 78.05% |
投资现金 | -939.70万 | -1,221.66% |
融资现金 | 182.60万 | -37.21% |
现金净变动 | -904.20万 | -116.37% |
自由现金流 | -174.00万 | -128.89% |
简介
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
CEO
成立时间
2013
员工数量
923
